(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | -25.6MM | -304% |
Gross Profit | -15.8MM | -315% |
Cost Of Revenue | 5.2MM | +2% |
Operating Income | 3.9MM | -1% |
Operating Expenses | -19.8MM | - |
Net Income | -8.1MM | -305% |
R&D | 145K | +5% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
With its stock down 15% over the past three months, it is easy to disregard Utah Medical Products (NASDAQ:UTMD...
Utah Medical Products ( NASDAQ:UTMD ) Full Year 2023 Results Key Financial Results Revenue: US$50.2m (down 3.9% from FY...
Revenue Declines While Net Income and EPS Show Slight Increase
SALT LAKE CITY, UT - (NewMediaWire) - January 30, 2024 - With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) achieved financial results for the full year of 2023 consistent w...
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend of $0.30 per share on the 3rd of...
Utah Medical Products, Inc. ( NASDAQ:UTMD ) stock is about to trade ex-dividend in four days. Typically, the...
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...
Key Insights Institutions' substantial holdings in Utah Medical Products implies that they have significant influence...
Utah Medical Products, Inc. ( NASDAQ:UTMD ) will pay a dividend of $0.30 on the 3rd of January. The dividend yield is...